30
Edelweiss Research is also available on www.edelresearch.com, Bloomberg EDEL <GO>, Thomson First Call, Reuters and Factset. Edelweiss Securities Limited Pidilite (PIDI) is a high quality niche consumption play imbued with strong brand equity in under penetrated and high growth categories. The company has sustained its dominant position (Fevicol, M-seal have ~70% market share) by virtue of direct reach to influencers/end users, successful brand extensions, innovation spurred by robust R&D, out-of- the-box and catchy ads, acquisitions (ROFF, Mseal, Sargent Art, Hobby Ideas), limited competition and widespread distribution. Key risk/concerns are performance of its international portfolio (especially Brazil) and the Elastomer project. We expect 17% revenue CAGR with robust 20% PAT CAGR over FY14-16E. We initiate coverage with ‘BUY’. Consumer business will continue to sizzle Robust growth across segments spurred PIDI’s consumer & bazaar products (CBP) and industrial chemicals segments to post 19% and 14% CAGR, respectively, over FY08-13. Though we expect the CBP business to maintain growth momentum, the industrial chemicals business may grow at a slower pace (11.5% CAGR) over FY14-16E due to the economic slowdown. Overseas business (has been a drag) margins are likely to improve riding sales pick up (Bangladesh, Thailand fastest growth engines), effective management changes, price hikes and mix improvement. Direct connect, distribution and innovation key strengths PIDI directly reaches out to influencers/end users (furniture makers, plumbers, architects) via Dr. Fixit Institute, Fevicol Furniture Book and workshops which also enables it to introduce new products imbibing their feedback. Successful brand extensions (Marine Fevicol, Speedex), acquisitions (Suparshva) and low-priced SKUs amidst limited MNC competition provide it the bandwidth to outpace regional players. Outlook and valuations: Positive; initiate with ‘BUY’ We are positive on PIDI and expect re-rating to sustain. We value PIDI at 25x FY16E EPS and arrive at TP of INR357. At CMP, the stock is trading at 24.5x FY15E and 20.6x FY16E. We initiate coverage with ‘BUY/Sector Performer’ recommendation/ rating. INITIATING COVERAGE PIDILITE INDUSTRIES Adhesive growth: Ties that bind EDELWEISS 4D RATINGS Absolute Rating BUY Rating Relative to Sector Performer Risk Rating Relative to Sector Medium Sector Relative to Market Overweight MARKET DATA (R: PIDI.BO, B: PIDI IN) CMP : INR 294 Target Price : INR 357 52-week range (INR) : 304 / 206 Share in issue (mn) : 509.8 M cap (INR bn/USD mn) : 151 / 2,425 Avg. Daily Vol.BSE/NSE(‘000) : 280.0 SHARE HOLDING PATTERN (%) Current Q1FY14 Q4FY13 Promoters * 70.1 70.1 70.1 MF's, FI's & BK’s 5.3 5.4 5.6 FII's 13.7 13.9 13.6 Others 10.9 10.6 10.7 * Promoters pledged shares (% of share in issue) : Nil PRICE PERFORMANCE (%) Sensex Stock Stock over Sensex 1 month (1.9) 11.1 13.0 3 months 11.6 32.3 20.7 12 months 7.1 39.2 32.1 Abneesh Roy +91 22 6620 3141 [email protected] Click on image to view video Pooja Lath +91 22 6620 3075 [email protected] Tanmay Sharma +91 22 4040 7586 [email protected] India Equity Research| Consumer Goods November 28, 2013 Financials Year to March FY13 FY14E FY15E FY16E Revenues (INR mn) 36,781 42,997 50,600 58,960 Rev. growth (%) 17.6 16.9 17.7 16.5 EBITDA (INR mn) 5,990 7,358 8,712 10,145 Net profit (INR mn) 4,240 5,070 6,149 7,326 Shares outstanding (mn) 510 510 510 510 Diluted EPS (INR) 8.2 9.9 12.0 14.3 EPS growth (%) 32.9 20.1 21.3 19.1 Diluted P/E (x) 35.7 29.7 24.5 20.6 EV/EBITDA (x) 24.4 19.6 16.3 13.7 ROAE (%) 28.3 27.8 28.1 27.8

Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Embed Size (px)

Citation preview

Page 1: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Edelweiss Research is also available on www.edelresearch.com,

Bloomberg EDEL <GO>, Thomson First Call, Reuters and Factset.

Edelweiss Securities Limited

Pidilite (PIDI) is a high quality niche consumption play imbued with strong

brand equity in under penetrated and high growth categories. The

company has sustained its dominant position (Fevicol, M-seal have ~70%

market share) by virtue of direct reach to influencers/end users,

successful brand extensions, innovation spurred by robust R&D, out-of-

the-box and catchy ads, acquisitions (ROFF, Mseal, Sargent Art, Hobby

Ideas), limited competition and widespread distribution. Key

risk/concerns are performance of its international portfolio (especially

Brazil) and the Elastomer project. We expect 17% revenue CAGR with

robust 20% PAT CAGR over FY14-16E. We initiate coverage with ‘BUY’.

Consumer business will continue to sizzle

Robust growth across segments spurred PIDI’s consumer & bazaar products (CBP) and

industrial chemicals segments to post 19% and 14% CAGR, respectively, over FY08-13.

Though we expect the CBP business to maintain growth momentum, the industrial

chemicals business may grow at a slower pace (11.5% CAGR) over FY14-16E due to the

economic slowdown. Overseas business (has been a drag) margins are likely to improve

riding sales pick up (Bangladesh, Thailand fastest growth engines), effective

management changes, price hikes and mix improvement.

Direct connect, distribution and innovation key strengths

PIDI directly reaches out to influencers/end users (furniture makers, plumbers,

architects) via Dr. Fixit Institute, Fevicol Furniture Book and workshops which also

enables it to introduce new products imbibing their feedback. Successful brand

extensions (Marine Fevicol, Speedex), acquisitions (Suparshva) and low-priced SKUs

amidst limited MNC competition provide it the bandwidth to outpace regional players.

Outlook and valuations: Positive; initiate with ‘BUY’

We are positive on PIDI and expect re-rating to sustain. We value PIDI at 25x FY16E EPS

and arrive at TP of INR357. At CMP, the stock is trading at 24.5x FY15E and 20.6x

FY16E. We initiate coverage with ‘BUY/Sector Performer’ recommendation/ rating.

INITIATING COVERAGE

PIDILITE INDUSTRIES Adhesive growth: Ties that bind

EDELWEISS 4D RATINGS

Absolute Rating BUY

Rating Relative to Sector Performer

Risk Rating Relative to Sector Medium

Sector Relative to Market Overweight

MARKET DATA (R: PIDI.BO, B: PIDI IN)

CMP : INR 294

Target Price : INR 357

52-week range (INR) : 304 / 206

Share in issue (mn) : 509.8

M cap (INR bn/USD mn) : 151 / 2,425

Avg. Daily Vol.BSE/NSE(‘000) : 280.0

SHARE HOLDING PATTERN (%)

Current Q1FY14 Q4FY13

Promoters *

70.1 70.1 70.1

MF's, FI's & BK’s 5.3 5.4 5.6

FII's 13.7 13.9 13.6

Others 10.9 10.6 10.7

* Promoters pledged shares

(% of share in issue)

: Nil

PRICE PERFORMANCE (%)

Sensex Stock

Stock over

Sensex

1 month (1.9) 11.1 13.0

3 months 11.6 32.3 20.7

12 months 7.1 39.2 32.1

Abneesh Roy

+91 22 6620 3141

[email protected]

Click on image to view video

Pooja Lath

+91 22 6620 3075

[email protected]

Tanmay Sharma

+91 22 4040 7586

[email protected]

India Equity Research| Consumer Goods

November 28, 2013

Financials

Year to March FY13 FY14E FY15E FY16E

Revenues (INR mn) 36,781 42,997 50,600 58,960

Rev. growth (%) 17.6 16.9 17.7 16.5

EBITDA (INR mn) 5,990 7,358 8,712 10,145

Net profit (INR mn) 4,240 5,070 6,149 7,326

Shares outstanding (mn) 510 510 510 510

Diluted EPS (INR) 8.2 9.9 12.0 14.3

EPS growth (%) 32.9 20.1 21.3 19.1

Diluted P/E (x) 35.7 29.7 24.5 20.6

EV/EBITDA (x) 24.4 19.6 16.3 13.7

ROAE (%) 28.3 27.8 28.1 27.8

Page 2: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

2 Edelweiss Securities Limited

Investment Rationale Flagship brands to anchor growth

PIDI’s presence in niche, under-penetrated and high growth categories with limited

competition makes it a good play on Indian consumer goods spends. The niche presence

yields high gross margins, high barriers to entry, strong brand equity, mass acceptance and

superior growth opportunities.

Chart 1: Consumer & Bazaar product sales expected to grow at 19% CAGR over 14-16E

Source: Company, Edelweiss research

The adhesive & sealants segment, contributing 51% to total sales, houses strong brands like

Fevicol, M-seal and Fevistik under its umbrella. The company has near monopoly in this

segment with Fevicol and M-seal enjoying ~70% market share each in the adhesive and

sealants product categories, respectively. The category grew 18% YoY in FY13.

The second largest category, construction chemicals (contributing 20% to total sales), also

has strong brands, Dr. Fixit (largely used as waterproofing and repair solution) and Roff

(used as complete range of tile fixing solution) under its umbrella. This category grew 20%

YoY in FY13.

PIDI’s third largest category, art materials (contributing 10% to total sales), surged 35% YoY

in FY13. In art materials, the company has a host of brands like Hobby Ideas, Ranipal,

Motomax and Cyclo. Off late, the segment has seen significant growth on account of fresh

look at products, new product introductions, better communication and improved

distribution model.

Industrial products account for 19% of the company’s revenue. This segment has lower

margin vis-à-vis consumer and bazaar segment; it includes three sub-segments: (i) Industrial

adhesives: Being market leader, PIDI provides an extensive range of products catering to

packaging, cigarettes, stock labels, stickers, footwear, etc. (contributes 7% to company’s

revenue); (ii) Industrial resins: The company produces polymers and co-polymers for

industries like paints, non-woven and flocked fabrics and leather (contributes 6% to total

revenue); and (iii) Organic pigments and preparation: Pioneer in manufacturing Pigment

8,500

16,500

24,500

32,500

40,500

48,500

FY

08

FY

09

FY

10

FY

11

FY

12

FY

13

FY

14

E

FY

15

E

FY

16

E

(IN

R m

n)

“We keep our eyes and ears

open to what customers want,

while our strong R&D gets us

exactly the right products"

- M B Parekh,

Chairman & MD

Page 3: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

3 Edelweiss Securities Limited

Violet 23 in India. Market leader in pigment dispersions for textile segment; the segment

contributes around 6% to total revenue.

Since the industrial segment caters to various industries (textiles, leather, footwear, ink,

packaging, etc.) its growth pattern largely mirrors IIP growth figures.

In the others category, PIDI manufactures a variety of special acetates. Currently, these

products are under test marketing with special focus on niche segments targeted at import

substitution.

Chart 2: Robust growth across categories

Source: Company, Edelweiss research

Chart 3: EBIT margins strong in both categories especially in CBP

Source: Company, Edelweiss research

5.0

10.0

15.0

20.0

25.0

30.0

FY08 FY09 FY10 FY11 FY12 FY13

(% Y

oY

)

Consumer & Bazaar Speciality Industrial Chemical

10.0

14.0

18.0

22.0

26.0

30.0

FY08 FY09 FY10 FY11 FY12 FY13

(%)

Consumer & Bazaar Speciality Industrial Chemical

“It is the efforts that we put in to

create demand, which would

drive the sales growth for our

products.”

- Sandeep Batra,

Director Finance

Page 4: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

4 Edelweiss Securities Limited

Chart 4: Consumer & bazaar products’ sales split

Source: Company, Edelweiss research

Chart 5: Speciality industrial chemical sales split

Source: Company, Edelweiss research

PIDI commands a premium over competitors riding strong brand—our channel checks

indicate that Fevicol commands a premium of 10% over its nearest competitor Jivanjor

(Jubilant Industries)—and it has created a huge entry barrier in the adhesive segment.

The company’s recent launches in the premium end—Marine Fevicol (for furniture in

constant touch with water), Speedex (fast adhesives) and fabric glue—are growing faster

than base adhesives.

Huge brand equity is a high entry barrier

PIDI is not present in competitive consumer segments or well-penetrated segments; it

focuses on only niche sub-segments. This has resulted in the company developing market-

leading brands Fevicol, Dr Fixit and M-Seal. As there are no large competing products in

these sub-segments, it has developed products that now enjoy indisputable market

leadership.

0.0

20.0

40.0

60.0

80.0

100.0

FY08 FY09 FY10 FY11 FY12 FY13

(%)

Adhesives & Sealants Construction/Paint Chemical Art materials & others

0.0

20.0

40.0

60.0

80.0

100.0

FY08 FY09 FY10 FY11 FY12 FY13

(%)

Industrial resins Industrial adhesives Organic pigments and preparations

Page 5: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

5 Edelweiss Securities Limited

Table 1: Low competitive intensity creating a strong entry barrier

Source: Company, Edelweiss research

The company operates in categories where presence of large multi nationals is limited,

which enables it to outpace small regional players (who lack financial strength, economies of

scale and have poor distribution network and weak brand image) with aggressive ads and

product extensions. Though PIDI leads most categories it is present in, Huntsman's brand

Araldite (epoxy resin segment) is ahead of the former’s Fevitite, although Huntsman’s white

glue brand, Carpenter, has not met with much success.

The Henkel Group has presence in this industry and poses competition in industrial specialty

segment. The Sika Group, based in Switzerland, with significant presence in construction

chemicals poses competition. Similarly in eastern part of India, Dendrite from the Kolkata-

based Chandra's Chemical Enterprise, also has significant presence but not at a national

level. Pidilite faces competition in art and stationery segment from the likes of Camlin, Faber

Castle.

In the construction chemicals category PIDI is not affected by entry of large paint players

(Asian Paints) as penetration levels are low. Though Asian Paints is posing competition by

providing one-stop solution to retail users Dr.Fixit continues to remain the market leader in

the construction chemical business due to its strong relationship with architects and

builders. In our view, new entrants will have limited presence in this space and will help

expand the nascent category.

Segment Pidilite brands Competition brands Use

Adhesive & Sealant Fevicol, Fevistik, Fevikwik, Mseal,

Steelgrip, Feviquick

Jivanjor, Carpenter,

Araldite, Dendrite

Woodwork, Flooring, Upholstery,

Footwear, Plumbing, electrical and

decorative purposes

Construction chemical ROFF, Dr. Fixit, Fevimate Sika, Fosroc Waterproofing, Admixture, Tile fixing,

Floor hardening, Sealants, Heat reduction

coating

Art material & stationery Fevicryl, Hobby Idea, Fevicraft,

Sargent Art

Camlin, Faber Castle Education, Publication, Painting

Fabric care Ranipal Ujala Cloth brightner, Stain removal

Automotive Cyclo, Motomax Castrol Lubricant, Engine Oil, Maintenance,

Polishing

Decorative paints Wudfin, Piditint Asian Paints, Berger Wood finishing, Interior coating and wall

finishing

Industrial Adhesive Fevicol, Pidivyl, Tracol, Trisol,

Pidiprimer, Kondicryl

Henkel, Huntsman,

Sika, 3M, HB fuller

Packaging and converting, cigarette, book

binding, stickers, lamination and

labelling, Footwear

Textile Chemical Texcron, Dopcron, Pidifinish,

Pidicryl

BASF, Jubil iant Pigment dispersion, Pigment printing

Industrial Resin Pidivyl, Pidicryl, Pidinon BASF, Jubil iant Waterbased decorative paint, Industrial

paint, Coatings and Construction

chemical

Organic Pigments Azo, Quinacridone, Methyl Violet Clariant, Sudarshan Printing Ink, Paints, Plastic

Masterbatches, Textile Dispersions,

Rubber, Dry Colours

Leather Chemicals Pidisper, Pidicryl, Acrytan, Pilcide BASF, Jubil iant Fungicide, Bactericide, Degreasing agent,

Binder

Page 6: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

6 Edelweiss Securities Limited

Innovating and reinvigorating offerings to capture consumer pie

Strong brand: Consumer pull model

Since adhesive is a low involvement category, consumer tends to go with a superior brand

of good quality and durability. PIDI aptly exploited creative marketing strategies, including

successful advertising campaigns to make its brand generic name in the adhesive category.

Fevicol’s simple and creative advertisements, over the years, have always made an impact,

right from Bob Cristo wrestling with a chair, to a politician who is glued to his chair, to the

hen that laid unbreakable eggs, to the overflowing bus, to the joint family that refuses to fall

apart and the latest animated elephants bond Raksha Bandhan. Use of Fevicol brand name

in the item number Fevicol Se featured in Bollywood blockbuster Dabangg-2 is a huge

testimony to the brand’s media success.

Chart 6: A&P— helps build strong brands

Source: Company, Edelweiss research

Advertisements have created a pull for the white glue among retail consumers. This was the

first product in the category to generate sales not only from hardware stores, but also from

consumers who had a strong brand recall due to the creative and eye-catching television

commercials.

Connecting with end users—Carpenters

Fevicol has held most competitors at bay by establishing a strong connect with the major

driver of sales in furniture making (~85% unorganised market)—carpenters—by direct

marketing, which helped PIDI establish a strong recall for its brand in the white glue market.

To further strengthen its connect, Fevicol introduced Fevicol Furniture Booklets, which

showcased furniture designs with illustrations and measurements. Also, Fevicol Champion’s

Club (FCC) was another initiative introduced by the company as a platform for carpenters to

enhance their social contacts and be part of a social network.

2.0

2.6

3.2

3.8

4.4

5.0

FY08 FY09 FY10 FY11 FY12 FY13

(as

% o

f sa

les)

Page 7: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

7 Edelweiss Securities Limited

Table 2: Promotional activities

Source: Company, Edelweiss research

M-Seal and Steelgrip are also leading brands in the epoxy sealants and PVC insulation tape

categories, respectively. Roff is the second brand after Dr. Fixit in the construction chemicals

portfolio.

Dr. Fixit Institute of Structural Protection & Rehabilitation (DFI – SPR) is an initiative by

PIDI to develop the service life of civil structures in India. It is a non-profit organisation

operating as a knowledge centre to create awareness and skill development among

professionals about waterproofing, repair and rehabilitation via training programmes,

workshops and seminars.

PIDI in its endeavour to reach out to users launched Fevicol Furniture Book showcasing

samples of furniture designs, suitable for Indian homes, commercial spaces, offices,

showrooms, restaurants, farm houses, bungalows etc. The company has launched 31

successful volumes of this book riding high on numerous design variants, user-friendly

approach, easy to follow furniture diagrams and affordable price.

The company, under the aegis of its Arts, Stationery and Fabrics division, does the Fevicol

Science Project Challenge. It is an annual nationwide competition that identifies talent from

across schools. This contest encourages students to think about topics that are related to

their everyday life, futuristic concepts and make 3-D models of their interpretations of the

subject/topic. The 3-D modeling is to promote the “Learning by doing” attitude so that

young minds understand the theory as well as the actual working of concepts.

Leveraging brand Fevicol to promote other products, SKUs

PIDI has been successful in keeping alive the freshness quotient of its brands by consistently

innovating and introducing variants catering to customer needs. As part of its strategy, the

company has successfully leveraged its Fevicol brand to fill gaps by targeting specific

consumer needs with Fevikwik, Fevistik, Fevitite, etc, in new sub categories. To reach out to

retail markets, Fevicol was launched in collapsible tubes at an attractive price of INR5 to

capture the mass market; other smaller packs also helped encourage use by school

students, professional and educational institutions. The new packaging formats transformed

the brand from an industrial product to all-purpose glue.

Activities Purpose

Fevicol Furniture Book Publishing magazines for 300,000 carpenters every quarter showcasing furniture designs

with i l lustrations, measurements, etc aimed to enlighten carpenters on the recent trends

and styles

Fevicol Champion's Club ~45000 member club that provides a platform for carpenters to increase their social

contacts and to make them a part of the social network

Different courses Courses aimed for housewives for the effective use of art material

Dr Fixit Institute Knowledge centre aimed to help Indian construction experts interact with the

international experts in the field of waterproofing and building repairs

Fevicol science project challenge Initiated an inter school contest in 2011 tp promote its hobby ideas products reaching

over 330 schools across India and over 55,000 students

Page 8: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

8 Edelweiss Securities Limited

In FY08, the company introduced Fevicol craft adhesive at INR2 and Fevigum at INR1 which

made high quality adhesives available to consumers at very affordable prices. The company

has continued to attract consumers with its strategically priced LUPs to drive volumes.

PIDI also introduced Fevistik Blue and Fevistik Purple in FY10. Unlike white glue, these

coloured sticks when applied appear coloured, but the colour disappears after a few

seconds, enabling young children to see and control the application of glue.

Brand extension: Tried and tested method to boost brand recall

As per Nielsen, in India, extensions of existing brands are five times more successful than a

new brand. Brand extensions can grow incremental sales up to 38% and contribute as much

as 30% to parent brand sales apart from promoting brand equity. Brand extensions leverage

equity of the parent brand, lead to faster adoption and deliver higher marketing efficiency.

On similar lines, PIDI launched Fevicol SPEEDX, a premium white adhesive which is India’s

first fast-setting adhesive. This water-based adhesive is apt when time is of essence. It is

based on Nano Magnet Technology, which brings molecules closer very fast, resulting in an

exceptionally strong bond. It provides handling strength in just two hours against six to eight

hours taken by regular adhesives.

Similarly, in the construction chemicals segment several new products were launched under

Dr. Fixit brand—Dr. Fixit Low Energy Consumption systems (for high-end waterproofing

coupled with insulation for terraces and walls), Dr. Fixit Extensa (high-end puncture-proof

waterproof coating for roofs & basements) and Dr. Fixit Bathseal Kit (for comprehensive and

long lasting waterproofing for bathrooms).

Premium products in glue doing well

The company’s launches in premium adhesives are doing well. Marine Fevicol (for furniture

in constant touch with water), Speedex (fast adhesives) and fabric glue are growing faster

than base adhesives.

Strong brand equity enables price hikes to offset raw material inflation

VAM and packaging materials (HDPE, LLP) are the key raw materials for PIDI, constituting

30-35% of raw material costs. VAM, a petrochemical produced from ethylene is a crude oil

derivative, which the company imports from Singapore (as imports are cheaper than captive

production). Hence, INR depreciation has a bearing on costs. The company tries to contain

COGS inflation by taking price hikes, which we believe, is not difficult due to its strong brand

equity and high market share.

Page 9: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

9 Edelweiss Securities Limited

Chart 7: Stable gross margin despite RM volatility due to high pricing power

Source: Company, Edelweiss research

Chart 8: EBITDA margin stable despite rising crude prices

Source: Company, Edelweiss research

Rich product portfolio backed by strong R&D

PIDI has successfully identified and met potential consumer demands (water proofing, damp

proofing) backed by its strong in house R&D capabilities and an innovation centre in

Singapore (two third sales come from products pioneered in India).

33.0

38.0

43.0

48.0

53.0

58.0

FY08 FY09 FY10 FY11 FY12 FY13

(%)

0.0

5.0

10.0

15.0

20.0

25.0

2,000

3,000

4,000

5,000

6,000

7,000

Q1

FY

10

Q2

FY

10

Q3

FY

10

Q4

FY

10

Q1

FY

11

Q2

FY

11

Q3

FY

11

Q4

FY

11

Q1

FY

12

Q2

FY

12

Q3

FY

12

Q4

FY

12

Q1

FY

13

Q2

FY

13

Q3

FY

13

Q4

FY

13

Q1

FY

14

Q2

FY

14

(%)

(IN

R/b

arr

el)

Page 10: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

10 Edelweiss Securities Limited

Chart 9: R&D spends - Key to maintaining leadership

Source: Company, Edelweiss research

The construction chemical category will be one of the faster growth drivers (Dr. Fixit and

ROFF) as it is a play on retail consumer’s discretionary income and in construction activity.

Its recent innovations like Fevicol Glue Drop, Dr Fixit Waterbar and smaller sized SKUs of

Fevikwik at INR 5 have done well. It has an extensive product portfolio across segments like

adhesives, sealants, fabric care, decorative paints, arts & stationery material and organic

pigments.

The company has a major research and development facility at Kondivita, Mumbai. Further,

the Pidilite Innovation Centre (company’s step-down subsidiary) was incorporated in

Singapore in December 2006 with the objective of undertaking R&D activities. The group’s

R&D team works closely with marketing and technical service teams to upgrade existing

products and develop new products to meet the continuously changing requirements. The

group has developed most of its products through strong in-house research and

development teams. The company aims to continuously develop new and innovative

products for consumers, craftsmen and industries.

Acquisitions: Key to augmenting product capability and new markets

PIDI intends to pursue acquisition opportunities in a disciplined and planned manner. The

company uses this strategy to add to its existing portfolio of products, complement

manufacturing and research and development facilities and gain access to new markets as

well as increase market penetration in existing markets. The company, in the past, acquired

companies like ROFF, Mseal, Sargent Art, Hobby Ideas to consolidate its position in

respective segments. In Q1FY14, it acquired the adhesive business of Suparshva Adhesives

(sales less than 1% of PIDI’s sales). The slump sale agreement includes brands, know-how

and other assets pertaining to the adhesive business which is into various adhesives and

sells the same under the Falcofix brand. Suparshva Adhesives had a strong presence in

Maharashtra with its products are priced at a discount to Fevicol; it has good brand equity at

the lower end of the market with wood working intermediaries. PIDI plans to retain the

brand and leverage it in some of the other markets as well. The acquisition will help the

company reduce competition in Maharashtra.

0.40

0.42

0.44

0.46

0.48

0.50

FY10 FY11 FY12 FY13

(as

% o

f sa

les)

Page 11: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

11 Edelweiss Securities Limited

Table 3: Major acquisition- Successful record of acquiring and integrating businesses and brands

Source: Company, Edelweiss research

Management has no plans to enter any new line of business as of now, but is looking to

expand and strengthen its current portfolio.

Expansion in distribution reach

PIDI has an extensive distribution and marketing network, especially in the adhesive and

sealant industry. The company has a field force of over 1,000 representatives and each of

these representatives have 50 retailers/dealers under them. Distribution is a key

differentiator for the consumer and bazaar category and like Asian Paints, PIDI’s widespread

distribution is its key strength against competition.

Rural markets continue to drive growth

The company does not intend to vacate the LUP space (INR5 pack) as it is highly popular in

rural areas (growing faster than urban). In this price segment volume leverage offsets input

cost inflation.

Year Major Acquisition

2000 “M-Seal”, a brand of epoxy compounds was acquired.

2002 “Steelgrip”, a brand of PVC insulation tape was acquired.

2004 “Roff”, a brand of construction chemicals was acquired.

2005 Incorporated subsidiaries in Singapore, Brazil and Dubai to undertake its international operations.

Through its subsidiaries acquired Chemson, a Singapore based company manufacturing waterproof coating and

emulsion paints and Jupiter Chemicals LLC, a Dubai based company manufacturing construction chemicals

2006 “Tristar Colman” and “Fine Art”, brands, business and certain assets of canvas and student art colours and brushes

of drawing and painting, respectively, were acquired.

Bamco Limited, Thailand, a construction chemical company was acquired.

Pidil ite USA Inc, Delaware, a subsidiary of the Company, acquired the business and assets of Sargent Art Inc. (the

makers of art material range of products) and Cyclo Industries LLC (the sellers of automotive maintenance

Established a research and development centre in Singapore.

2007 Pidil ite Do Brazil Desenvolvimento De Negocios Ltda, a wholly-owned subsidiary of the Company, acquired Pulvitec

(adhesives, sealants and construction chemicals).

Acquired plant and machinery, patents, trademark and technology of Synthetic Elastomer (Polycholoroprene

Rubber) plant in June 2007.

2008 Acquired assets and business of branded sealants and adhesives from Hardcastle & Waud Manufacturing Co. Ltd

and associates (brands l ike Holdtite, Rustolene and Leakgaurd).

2010 Acquired the retail wood working brand of Henkel, i .e. Woodlok

2013 Acquired the adhesive business of Suparshva Adhesives; strong presence in Maharashtra with its products priced

at a discount to Fevicol; it has good brand equity at the lower end of the market with wood working intermediaries.

The slump sale agreement includes brands, know-how and other assets pertaining to the adhesive business (under

the “Falcofix” brand).

“In terms of looking at the split of

the demand I think it is the

smaller towns, the smaller

population agglomerations,

which are seeing stronger growth

than the larger Tier-1 cities.”

- Sandeep Batra,

Director Finance

Page 12: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

12 Edelweiss Securities Limited

Sensitivity analysis: Impact of INR depreciation

As PIDI imports 30-35% of its raw material including VAM (constituting ~10.5% of total

COGS) fluctuation in INR impacts the company’s margin.

As per our calculations, for a 10% INR depreciation (considering 35% of RM to be imported)

the EBITDA will decrease by 11.7% and the PAT will decrease by 16.7% keeping all other

variables constant. In order to mitigate this impact of INR depreciation (to maintain EBITDA

margin at 16.3% as in FY13) PIDI will have to take a price hike of 2%.

However, taking into account exports (constitute ~9% of total sales) the impact is lesser.

Taking into account export earnings, 10% INR depreciation leads to 6.2% decrease in EBITDA

and 8.9% fall in PAT.

Table 4: Sensitivity analysis of INR depreciation on EBITDA and PAT

Source: Edelweiss research

FY13A 10% depreciation % change 10% depreciation % change

Sales (inc 9% exports) 36,781 36,781 37,112

Imported RM (35% COGS) 7,028 7,731 7,731

Other 13,053 13,053 13,053

Total COGS 20,081 20,784 20,784

Other costs 10,710 10,710 10,710

EBITDA 5,990 5,287 (11.7) 5,618 (6.2)

Depreciation 686 686 686

Other income 705 705 705

EBIT 6,009 5,306 5,637

Interest costs 214 214 214

PBT 5,795 5,092 5,423

Taxes 1,595 1,595 1,595

Core profit 4,200 3,497 (16.7) 3,828 (8.9)

(INR mn)

Without considering export benefit With export benefit

Page 13: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

13 Edelweiss Securities Limited

Table 5: Peer comparison table

Source: Edelweiss research

Over the past two years the entire Consumer pack has seen re-rating due to sustained

robust performance (on a relative basis) despite macro-economic slowdown which has

affected most other sectors. PIDI has also been a party to this re-rating phenomenon.

Company Market Mcap Div yield(%)

CAGR

(%)

Price (INR) (INR bn) FY14E FY15E FY14E FY15E FY14E FY15E FY14E FY15E FY14E FY13-15E

Pidil ite 294 151 9.9 12.0 29.7 24.5 19.6 16.3 27.8 28.1 1.0 21.0

ITC 314 2,451 11.3 13.2 27.8 23.7 18.2 15.4 36.4 38.2 2.5 17.3

Hindustan Unilever 590 1,275 16.6 18.6 35.6 31.7 26.4 23.0 104.5 87.6 1.9 9.2

Nestle* 5,224 504 121.1 146.8 43.1 35.6 23.9 20.4 56.2 52.6 1.3 15.1

Asian Paints 505 484 14.3 18.2 35.4 27.8 22.2 18.2 36.5 38.1 1.4 25.1

United Spirits 2,628 331 41.0 58.3 64.2 45.1 28.6 24.3 9.5 10.5 0.3 NM

Dabur 163 284 5.3 6.5 30.8 25.0 23.1 18.4 38.7 37.7 1.4 21.9

Godrej Consumer 904 307 23.6 28.9 38.3 31.3 26.8 21.7 22.5 23.7 1.0 21.4

GSK Consumer 4,340 182 160.6 150.2 27.0 28.9 18.3 19.5 43.8 33.4 1.4 20.3

Colgate 1,238 168 38.9 45.2 31.8 27.4 23.0 19.5 100.3 101.9 2.7 11.3

Marico 212 130 7.8 9.2 27.1 23.0 18.1 14.9 22.9 22.1 0.4 27.7

Emami 489 74 17.3 20.8 28.2 23.6 24.1 20.0 46.4 46.8 1.5 21.2

Bajaj Corp 233 34 12.8 14.5 18.2 16.0 15.1 13.0 37.1 38.0 2.8 13.6

FMCG - Mean 37.0 41.7 33.6 28.0 22.1 18.8 44.8 43.0 1.5 18.8

* CY numbers

EPS P/E( x) EV/EBITDA(x) ROAE (%)

Page 14: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

14 Edelweiss Securities Limited

Valuation

PIDI’s broad product portfolio provides a good play in the consumer and specialty chemicals

space by virtue of its strong presence in under-penetrated and high-growth categories. We

are enthused by the company’s strong earnings growth, increasing market share, robust

volume growth and pricing power. Its strong brand equity with undisputed leadership and

sustained high volume growth reinforces our belief in the company’s high growth potential.

However, we will closely monitor the performance of its international operations, raw

material inflation (mainly due to INR depreciation) and development in the Elastomer

project.

We assign a target multiple of 25x to FY16E EPS arriving at a target price of INR357, based

on our strong conviction of sustained dominant position in various categories it operates by

virtue of direct reach to influencers/end users, successful brand extensions, innovation

spurred by robust R&D, out-of-the-box ads, acquisitions (ROFF, Mseal, Sargent Art, Hobby

Ideas), limited competition and widespread distribution. We have valued the stock at a

discount to Asian Paints (owing to PIDI’s smaller size) and other single product MNC

companies like Colgate and GSK Consumer who are also clear leaders in the categories they

operate in.

PIDI’s earnings are expected to grow at 20% CAGR over FY14‐16E. Strong cash generation

and better visibility of its earnings over the next two years are an added attraction. We

expect current multiples to sustain due to strong earnings growth.

Hence, we initiate coverage on the stock with a ‘BUY’ recommendation. On relative return

basis, the stock is rated ‘Sector Performer’.

Chart 10: 1 year forward PE band; re-rating to sustain

Source: Edelweiss research

0

70

140

210

280

350

No

v-0

8

Ma

y-0

9

No

v-0

9

Ma

y-1

0

No

v-1

0

Ma

y-1

1

No

v-1

1

Ma

y-1

2

No

v-1

2

Ma

y-1

3

No

v-1

3

(IN

R)

10x

15x

20x

25x

30x

Page 15: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

15 Edelweiss Securities Limited

Key Risks

Competition getting stiffer in some segments

The rapidly expanding sector is luring new players. Also, competitors are aggressively

innovating and enhancing efforts to increase contribution from this segment. PIDI will,

therefore, need to drive its resources towards augmenting A&P to back up sales and

maintain brand loyalty. Also, failure to develop new products or to successfully implement

productivity and cost-reduction initiatives may harm the company’s competitive position.

Rupee depreciation has a bearing on margins

A rise in crude oil price and INR depreciation could hurt PIDI’s margin as VAM and packaging

costs form 30-35% of total raw material costs. EBIT margins may come under pressure

unless product mix improves or commensurate price hikes are taken (price hikes seem to be

a challenging task amidst current macro economic slowdown).

Synthetic Elastomer project a drag

Construction work on the synthetic Elastomer project remains suspended as PIDI is

evaluating various alternatives regarding the project’s future. The company is looking for

strategic investors for this project. It has spent INR3.6bn on the project and any negative

development (write-off of entire capex) on this project may have a bearing on PIDI.

International operations remain subdued

Losses in international business continue. Brazilian operations remain the key issue.

Economic slowdown

With urban areas contributing significantly to sales, a slowdown in economic growth may

negatively affect the company’s business. Slowdown is sharper in discretionary segment

against directly consumer related segments.

Page 16: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

16 Edelweiss Securities Limited

Porter’s 5 Forces Analysis

Threat of new competition: Low

PIDI has established strong market leadership in categories it operates in owing to strong

brand equity, focus on R&D, robust distribution network and differentiated and well-

targeted advertising.

Threat of substitutes: Low

It faces low competition from substitutes.

Bargaining power of customers: Low

Being market leader, PIDI commands strong pricing power with competitors following suit.

Bargaining power of suppliers: Medium

30-35% of its raw material is imported and thus has a bearing of INR depreciation. PIDI

needs to take commensurate price hikes to counter raw material inflation.

Competitive rivalry: Low

The company operates in niche categories where there is limited competition from large

multinationals and it can easily exploit small regional players with its existing brand equity

and creative marketing.

Fig. 1: SWOT analysis

Source: Edelweiss research

Strength

Differentiated products

Strong brand equity

Smart advertising and

educating decision makers

Relevant acquisitions

Opportunities

Premiumization focus

Ability to spot

opportunities in

commodity play

(terminator, etc.)

Weakness

Uncertainty on

Elastomer project

Weak international

business performance

Threats

Entry of paint players

in the water-proofing space

Weakness in Indian rupee

Global geopolitical

uncertainties

Page 17: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

17 Edelweiss Securities Limited

Company Description

PIDI is the pioneer in consumer and specialties chemicals in India, with diverse product

range that includes adhesives and sealants, construction and paint chemicals, automotive

chemicals, art materials, industrial adhesives, industrial and textile resins and organic

pigments and preparations. Most of its products have been developed through strong in-

house R&D. The company is the market leader in adhesives and sealants, construction

chemicals, hobby colours and polymer emulsions in India. Brand Fevicol has become

synonymous with adhesives to Indian consumers and is ranked amongst the most trusted

brands in the country. Pidilite is also growing its international presence through acquisitions

and setting up manufacturing facilities and sales offices in important regions around the

world.

Pidilite faces limited competition as in most of its segments there are only a few large

companies with national presence. A large number of small size companies are active

regionally.

Business mix

Fig. 2: Consumer Bazaar dominates the business mix

Source: Edelweiss research

Consumer & bazaar products

Consumer & bazaar products account for 81% of the company’s revenue. It includes various

segments like adhesives and sealants, construction chemicals, art materials and stationery

and others like fabric care, automotive and decorative segments. These products are widely

used by carpenters, painters, plumbers, mechanics, households, students, offices, etc.

Pidilite

Consumer and Bazaar

products (81%)

Industrial speciality

products (19%)

Adhesives and

sealants (51%)

Industrial

adhesives (7%)

Construction

chemicals (20%)Industrial resins (6%)

Art Material and

stationery (10%)

Organic pigments and

preparation (6%)

Page 18: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

18 Edelweiss Securities Limited

Table 6: Consumer and Bazaar product segmentation

Source: Company, Edelweiss research

Adhesive and sealants: The organised adhesive market in India is estimated at ~INR 10 bn

with Pidilite being a major player, garnering 70% market share. Pidilite has established

leadership position in adhesives and sealants segment with it contributing 51% to

company’s revenue. The company offers extensive range of products under this segment

used in woodworking, upholstery & flooring, footwear, automotive aftermarket, plumbing

and electrical and for decorative purposes. Brand Fevicol has become synonymous with

adhesives to millions in India and a huge entry barrier for other competing products. The

closest competitor is Jubilant Organosys with its Jivanjor brand. Huntsman's brand Araldite

is the leader in the epoxy resin segment, piping Pidilite's Fevitite into second place, although

its white glue brand, Carpenter, has not been successful. The company faces competition

from various local brands. This industry is expected to post 10-12% in the long term. Fevicol

is marketed in 54 countries worldwide. In India alone it is available at over 50,000 stores

across the country.

Construction chemicals: These are materials that are added to a building structure to

increase its life and provide stability and used during pre-construction and post-construction

stages. These include extensive range of products like waterproofing material, admixtures,

tile fixing solution, floor hardener, sealants, grouts, heat reduction coatings. Current market

size of this segment is estimated to be INR ~18 bn. It contributes ~20% to total revenue. This

segment has delivered 30-35% CAGR over the past five years and is expected to be the

company’s growth driver and post CAGR of more than 25%. Pidilite owns two well known

brands under this category viz., Dr. FIXIT and ROFF used for varied application in

waterproofing, sealing, flooring, concrete treatment & plastering. The Sika Group, based in

Switzerland, with significant presence in construction chemicals poses stiff competition.

Art Material and stationery: Pidilite has an extensive range of art material catering to

education, hobby and fine art segments. Products under this segment are complemented

with books, videos and training material to make them popular among the targeted end

user segment. The company’s position in this segment was strengthened with the

acquisition of Traistar Colman brand in India and The Sargent Art brand by its subsidiary in

the US. Various products manufactured under this product portfolio are tempera colours,

crayons, chalks, markers, poster paints, water colours, clay, fabric colours, glass colours,

Segment Pidilite brands Competition brands Use

Adhesive & Sealant Fevicol, Fevistik, Fevikwik, Mseal,

Steelgrip, Feviquick

Jivanjor, Carpenter,

Araldite, Dendrite

Woodwork, Flooring, Upholstery,

Footwear, Plumbing, electrical and

decorative purposes

Construction chemical ROFF, Dr. Fixit, Fevimate Sika, Fosroc Waterproofing, Admixture, Tile fixing,

Floor hardening, Sealants, Heat reduction

coating

Art material & stationery Fevicryl, Hobby Idea, Fevicraft,

Sargent Art

Camlin, Faber Castle Education, Publication, Painting

Fabric care Ranipal Ujala Cloth brightner, Stain removal

Automotive Cyclo, Motomax Castrol Lubricant, Engine Oil, Maintenance,

Polishing

Decorative paints Wudfin, Piditint Asian Paints, Berger Wood finishing, Interior coating and wall

finishing

Consumer & Bazaar

Page 19: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

19 Edelweiss Securities Limited

ceramic colours, moulding putty, brushes, hobby kits, hobby books, etc. This segment

contributes around 10% to the company’s total revenue. This segment is expected to grow

at 10-12% in long term. This product range is dominated by competitiors Camlin and Faber

Castle.

Others: This includes a wide range of products like fabric care, car care and decorative

paints. Pidilite acquired Cyclo brand in June 2006; its product range includes maintenance,

performance and appearance products for DIY (Do-it-Yourself) and professional car care

segment. Cyclo products are sold in US and over 50 other countries. Ranipal has a good

market presence in the fabric care segment. Main competitor in fabric care segment is

Jyothy Lab’s Ujala.

Industrial specialty products

Industrial specialty accounts for 19% of the company’s revenue. This segment has lower

margins vis-à-vis consumer and bazaar segment. The Henkel Group has presence in this

industry and poses severe competition.

Table 7: Industrial products’ segmentation

Source: Company, Edelweiss research

Industrial adhesives: Being market leader, Pidilite provides extensive range of products

catering to packaging, cigarettes, stock labels, stickers, footwear, etc. This segment

contributes 7% to company’s revenue.

Industrial resins: It contributes 6% to total revenue. The company produces polymers and

co-polymers for industries like paints, non-woven and flocked fabrics and leather.

Organic pigments and preparation: Pioneer in manufacturing Pigment Violet 23 in India.

Market leader in pigment dispersions for textile segment, segment contributes to around

6% to total revenue.

International business

Pidilite exports to more than 80 countries and has 14 overseas subsidiaries (four direct and

10 step-down subsidiaries) operating across various geographies in the world. The

company’s overseas subsidiaries, including US, Brazil, Thailand, Singapore, Dubai, Egypt and

Bangladesh, contribute ~11% to consolidated sales. However, most subsidiaries are loss

Industrial products

Industrial Adhesive Fevicol, Pidivyl, Tracol, Trisol,

Pidiprimer, Kondicryl

Henkel, Huntsman,

Sika, 3M, HB fuller

Packaging and converting, cigarette, book

binding, stickers, lamination and

labell ing, Footwear

Textile Chemical Texcron, Dopcron, Pidifinish,

Pidicryl

BASF, Jubiliant Pigment dispersion, Pigment printing

Industrial Resin Pidivyl, Pidicryl, Pidinon BASF, Jubiliant Waterbased decorative paint, Industrial

paint, Coatings and Construction

chemical

Organic Pigments Azo, Quinacridone, Methyl Violet Clariant, Sudarshan Printing Ink, Paints, Plastic

Masterbatches, Textile Dispersions,

Rubber, Dry Colours

Leather Chemicals Pidisper, Pidicryl, Acrytan, Pilcide BASF, Jubiliant Fungicide, Bactericide, Degreasing agent,

Binder

Page 20: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

20 Edelweiss Securities Limited

making mainly due to small scale of operation, geopolitical issues, cost pressure and strong

competition. The company has taken major initiative to curtail overseas losses by shutting

down unviable subsidiaries and changing the management in the nonperforming

geographies. The benefits from appointment of new CEO in December 2012 to flow in

coming years which is expected to help sustain a better international business performance.

Table 8: Snapshot of international subsidiaries’ performance

Source: Company, Edelweiss research

Manufacturing facilities: Pidilite has seventeen manufacturing facilities and Research &

Development facility at Kondivita, Mumbai for which it has obtained EMS (Environment

Management System)/OHSAS (Occupational Health & Safety Assessment System)

Certification. In FY13 the Company commissioned a manufacturing unit at Mahad for

producing PVC film. Apart from company owned plants, it contracts third party

manufacturers for a few of its products. Pidilite is the only manufacturer of VAM in India

with an installed capacity of 30,000 MT per annum. Due to the global demand-supply

situation it was unviable to manufacture in house and hence the plant remained shut during

FY13. The company has started manufacturing few speciality acetates at the plant which

have received positive feedback from the markets.

Awards:

• Fevicol was ranked as India’s 45th Most Trusted Brand in 2012 in Brand Equity’s Most

Trusted brands survey

• Fevicol was also ranked 3rd Most Trusted Brand in the Household Care Category

• Fevicol was ranked amongst the Most Trusted Brands list for 5 consecutive years

• Fevicol was a recipient of the Zee Business Brand Excellence Award

• A 40 feet raincoat was installed on a building by Dr. Fixit Raincoat. This won a Gold

award for Madison Media in the Exchange4media Outdoor Awards

(INR mn)

International subsidiaries Country FY09 FY10 FY11 FY12 FY13 FY09 FY10 FY11 FY12 FY13

Pidi lite Speciality Chemicals Bangladesh Pvt Ltd Bangladesh NA 40 119 146 231 NA 0 5 6 13

Pulvitec do Brasil Brazi l 802 1,141 1,316 1,282 1,263 (200) (8) (88) (217) (416)

Pidi lite Industries Trading Co. Ltd China NA NA 3 15 20 NA NA (1) 1 1

Pidi lite Industries Egypt SAE Africa NA 16 60 124 146 (2) (27) (20) (23) (15)

PIL Trading LLC Africa NA 28 69 48 50 NA (2) (21) (15) (2)

PT Pidi lite Indonesia Indonesia 16 30 4 3 8 (12) 3 (1) (2) (2)

Pidi lite Middle East Ltd Middle East 3 NA NA NA NA 3 (0) (242) (30) (1)

Jupiter Chemicals LLC Middle East 194 188 106 154 98 (54) (63) (87) (44) (34)

Pidi lite International Pte Ltd Singapore 6 8 12 15 19 (2) (66) (3) (23) 9

Pidi lite Innovation Centre Pte Ltd Singapore 25 25 54 79 80 (1) (5) (9) (5) 6

Pidi lite Bamco Ltd Thailand 154 170 185 226 316 (27) (4) (6) (1) 9

Bamco Supply and Services Ltd Thailand 5 15 23 42 47 1 1 1 6 5

Pidi lite USA USA 1,250 1,114 1,220 1,364 1,604 (90) (47) 14 25 (13)

Pidi lite South East Asia Thailand 1.4 0 - 0 - (1) - -

Revenues Profit/(Loss)

Page 21: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

21 Edelweiss Securities Limited

Key Management Personnel

Mr. Sushilkumar K. Parekh: Mr. S.K. Parekh is the current Vice Chairman of the company

and is the promoter director. He has served as the non executive Vice Chairman since 1969

with a vast experience of more than 57 years in the industry. He is also a director of Parekh

Marketing, Pidichem, Fevicol, Kalva Marketing and Services, Ruchiket and Pargro

Investments.

Mr. Madhukar B. Parekh: After Mr. Balvant K. Parekh passed away Mr. M.B. Parekh was

made the Chairman of the company w.e.f. May 28, 2013. He is also Managing Director of

the company and has served as the Director of the company since 1972. He also serves as

the Managing Director of Vinyl Chemicals India and has been an Independent Non Executive

Director of Excel Industries since March 25, 2005. Mr. Parekh holds a Bachelor's Degree in

Chemical Engineering from UDCT and an M.S in Chemical Engineering from University of

Wisconsin, US. He has more than 38 years of experience in the industry.

Mr. Narendrakumar K. Parekh: Mr. N.K. Parekh is the Joint Managing Director and

Executive Director of the company. He is also a Director of Vinyl Chemicals (India), Fevicol

Company, Parkem Dyes and Chemicals and holds senior position in other companies as well.

He is a qualified Technologist for Dyes and Intermediates and a qualified Chemical Engineer

[B.Sc., B.Sc. (Tech), M.S.Chem Engg (U.S.A)] and has experience in the industry for over 44

years.

Mr. Apurva N. Parekh: Mr. A.N. Parekh is the Whole Time Director of the company since

July 2005. He is a promoter director of the company and has been working with PIDI since

1996. Mr. Parekh is a Chemical Engineer with qualification of B.S. Chem. Engg. (U.S.A.) and

has total business experience of 17 years.

Mr. Ajay B. Parekh: Mr. A. B. Parekh is the Whole Time Director of the company since 1985.

He is B.Chem (Engg.), Masters of Business Administration (U.S.A.). He is also the director of

Vacuum Forming, Ishijas Chemicals, Vapkon Finance & Investment and has experience of

over 25 years.

Mr. Sandeep Batra: Mr. Sandeep Batra, Director – Finance of the Company, was appointed

as a Wholetime Director with effect from 1 April 2007. Mr. Batra joined the ICI Group in

1988. He is a Chartered Accountant and has held a variety of finance, commercial and

business roles.

Page 22: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Consumer Goods

22 Edelweiss Securities Limited

Financial Outlook

Revenue expected to post 17% CAGR over FY14-16E

With increased consumption and discretionary spending, recovery in real estate and

construction sector picking up, PIDI is set to achieve a top line CAGR of ~17% over FY14-16E.

Chart 11: Revenues to continue strong growth trend

Source: Company, Edelweiss research

EBITDA margin likely to be stable over FY14-16

With expected A&P spends to return to earlier level of ~3.5% of sales cushioning EBITDA

margin. The company has effected price hikes in the past to offset input cost inflation and

being the market leader in the category it is present in, we expect margin to be sustainable

over the long term.

Chart 12: EBITDA margin stable

Source: Company, Edelweiss research

0.0

5.0

10.0

15.0

20.0

25.0

10,000

20,000

30,000

40,000

50,000

60,000

FY09 FY10 FY11 FY12 FY13 FY14E FY15E FY16E

(%)

(IN

R m

n)

Total revenues % growth YoY

0.0

4.0

8.0

12.0

16.0

20.0

0

2,400

4,800

7,200

9,600

12,000

FY

08

FY

09

FY

10

FY

11

FY

12

FY

13

FY

14

E

FY

15

E

FY

16

E

(%)

(IN

R m

n)

EBITDA EBITDA Margin

Page 23: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

Pidilite

23 Edelweiss Securities Limited

PAT likely to post 20% CAGR over FY14-16E

EBITDA margin expansion to aid PAT growth of 20% CAGR over FY14-16E. With new product

launches and sustained brand equity, long-term PAT growth prospect remains intact.

Chart 13: Strong PAT growth

Source: Company, Edelweiss research

Strong balance sheet fuel for further acquisitions, expansions

With negligible debt on its books (debt is for working capital needs; on an overall basis it is

expected to end at a net cash level of ~INR5.4bn in FY14E), PIDI is in a comfortable position

with room for further acquisitions and expansions.

Robust return ratios

Return ratios will emulate PAT margin and growth trend. However, further delay and

additional capital infusion for the Elastomer project may have an adverse impact on return

ratios.

0.0

2.8

5.6

8.4

11.2

14.0

0

1,600

3,200

4,800

6,400

8,000

FY08 FY09 FY10 FY11 FY12 FY13 FY14E FY15E FY16E

(%)

(IN

R m

n)

PAT PAT margins

Page 24: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

24 Edelweiss Securities Limited

Consumer Goods

Financial Statements

Assumptions

FY13 FY14E FY15E FY16E

GDP(Y-o-Y %) 5.0 4.8 6.0 6.5

Inflation (Avg) 7.4 6.0 6.0 6.0

Repo rate (exit rate) 7.5 8.3 7.3 6.0

USD/INR (Avg) 54.5 62.0 60.0 60.0

Company Assumptions

Sales growth assumptions

Consumer & Bazaar 20.7 19.0 19.7 18.2

Adhesive & Sealant 17.0 19.0 21.0 19.0

Construction and Chemicals 20.7 20.5 20.0 18.5

Art Materials and Others 44.8 16.0 12.0 13.0

Speciality Industrial Chemical 8.5 10.7 12.1 10.9

Industrial Adhesive 0.4 11.0 13.0 10.0

Industrial Resin (0.8) 8.5 12.0 11.0

Organic pigments &

preparation

34.5 12.5 11.0 12.0

Cost assumptions

COGS as % of sales 54.6 54.8 55.0 55.2

Staff costs as % of sales 10.2 10.2 10.1 10.1

A&P as % of sales 4.0 3.8 3.5 3.4

Financial assumptions

Tax rate 27.5 28.0 28.0 28.0

Debtor days 40 40 40 40

Inventory days 89 89 89 89

Payable days 41 42 42 42

Cash conversion cycle (days) 88 87 87 87

Depreciation as % of gross

block

5.6 5.7 5.7 5.7

Capex 1,045 1,120 1,300 1,100

Dividend as % of net profit 31.4 30.0 30.0 30.0

Yield on cash 16.2 14.5 14.0 14.5

Interest rate on outstanding

debt

9.9 35.0 25.0 25.0

Income statement (INR mn)

Year to March FY13 FY14E FY15E FY16E

Net revenues 36,781 42,997 50,600 58,960

Cost of goods sold 20,081 23,557 27,821 32,571

Gross profit 16,700 19,440 22,779 26,388

Staff costs 3,746 4,386 5,111 5,925

Advertisement & sales costs 1,473 1,634 1,771 2,005

Other expenses 5,492 6,063 7,185 8,313

EBITDA 5,990 7,358 8,712 10,145

Depreciation & Amortization 686 766 831 894

EBIT 5,304 6,592 7,881 9,251

Other Income 705 580 700 982

EBIT including other income 6,009 7,172 8,581 10,233

Net finance expense 214 166 84 109

PBT before exceptionals 5,795 7,005 8,497 10,124

Provision for taxes 1,595 1,962 2,379 2,835

Core profit 4,200 5,044 6,118 7,289

Extraordinary items 18 - - -

Minority Interest (2) (3) (4) (4)

Share in profit of associates 24 29 35 41

Profit after minority interest 4,240 5,070 6,149 7,326

Equity shares outstanding (mn) 510 510 510 510

EPS (INR) basic 8.2 9.9 12.0 14.3

Diluted shares (mn) 510 510 510 510

Diluted EPS (INR) 8.2 9.9 12.0 14.3

CEPS (INR) 6.5 7.5 9.0 10.5

DPS 2.6 3.0 3.6 4.3

Dividend payout ratio (%) 31.4 30.0 30.0 30.0

Tax rate 27.5 28.0 28.0 28.0

Common size metrics (%)

Year to March FY13 FY14E FY15E FY16E

Cost of materials 54.6 54.8 55.0 55.2

Employee costs 10.2 10.2 10.1 10.1

Advertising & sales costs 4.0 3.8 3.5 3.4

Other general expenditure 14.9 14.1 14.2 14.1

EBITDA margin 16.3 17.1 17.2 17.2

EBIT margin 14.4 15.3 15.6 15.7

Net profit margin 11.4 11.7 12.1 12.4

Growth metrics (%)

Year to March FY13 FY14E FY15E FY16E

Revenues 17.6 16.9 17.7 16.5

EBITDA 23.8 22.8 18.4 16.4

PBT 33.9 20.9 21.3 19.1

Net profit 30.2 20.1 21.3 19.1

EPS 32.9 20.1 21.3 19.1

Page 25: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

25 Edelweiss Securities Limited

Pidilite

Balance sheet (INR mn)

As on 31st March FY13 FY14E FY15E FY16E

Share capital 513 513 513 513

Reserves 16,003 19,293 23,284 28,038

Shareholders' funds 16,515 19,806 23,796 28,551

Minority 10 12 16 20

Long term borrowings 0 92 127 162

Short term borrowings 510 52 72 92

Current maturities of long term debt602 118 163 208

Borrowings 1,112 262 362 462

Deferred tax liability 499 499 499 499

Sources of funds 18,136 20,579 24,673 29,532

Tangible assets 5,656 6,090 6,358 6,564

Intangible assets 812 812 812 812

Capital work in progress 4,280 4,200 4,400 4,400

Total net fixed assets 10,747 11,101 11,570 11,776

Non current investments 85 85 85 85

Current investments 2,846 2,846 2,846 2,846

Cash and cash equivalents 1,506 2,800 5,055 8,183

Inventories 5,236 5,728 6,757 7,902

Sundry debtors 4,305 4,787 5,622 6,552

Loans and advances 914 914 914 914

Other assets 113 113 113 113

Total current assets (ex cash) 10,568 11,543 13,406 15,482

Trade payable 2,501 2,680 3,173 3,724

Other current liab. & provisions 5,115 5,115 5,115 5,115

Total current liab. & provisions 7,616 7,796 8,288 8,839

Net current assets (ex cash) 2,951 3,747 5,118 6,642

Uses of funds 18,136 20,579 24,673 29,532

BV (INR) 32.4 38.9 46.7 56.0

Free cash flow (INR mn)

Year to March FY13 FY14E FY15E FY16E

Net profit 4,240 5,070 6,149 7,326

Add: Non cash charge 860 906 885 966

Depreciation 686 766 831 894

Others 174 140 53 72

Gross cash flow 5,099 5,976 7,033 8,293

Less:Changes in WC (604) (796) (1,371) (1,525)

Cash from operations 4,495 5,180 5,663 6,768

Less: Capex 1,045 1,120 1,300 1,100

Free cash flow 3,451 4,061 4,363 5,668

Cash flow metric

Year to March FY13 FY14E FY15E FY16E

Operating cash flow 5,175 5,180 5,663 6,768

Financing cash flow (3,395) (2,767) (2,108) (2,539)

Investing cash flow (1,890) (1,120) (1,300) (1,100)

Change in cash (109) 1,294 2,255 3,128

Capex (1,045) (1,120) (1,300) (1,100)

Dividends paid (1,559) (1,779) (2,158) (2,572)

Ratios

Year to March FY13 FY14E FY15E FY16E

ROAE (%) 28.3 27.8 28.1 27.8

ROACE (%) 34.1 40.1 40.0 38.3

Debtor days 40 40 40 40

Inventory days 89 89 89 89

Payable days 41 42 42 42

Cash conversion cycle (days) 88 87 87 87

Current ratio 2.0 2.2 2.6 3.0

Debt/EBITDA 0.2 0.0 0.0 0.0

Debt/Equity 0.1 0.0 0.0 0.0

Adjusted debt/equity 0.1 0.0 0.0 0.0

Interest coverage (x) 24.8 39.7 93.4 84.6

Operating ratios

Year to March FY13 FY14E FY15E FY16E

Total asset turnover 2.1 2.2 2.2 2.2

Fixed asset turnover 5.8 6.4 7.2 8.1

Equity turnover 2.5 2.4 2.3 2.3

Valuation parameters

Year to March FY13 FY14E FY15E FY16E

Diluted EPS (INR) 8.2 9.9 12.0 14.3

Y-o-Y growth (%) 32.9 20.1 21.3 19.1

CEPS (INR) 6.5 7.5 9.0 10.5

Diluted P/E (x) 35.7 29.7 24.5 20.6

Price/BV (x) 9.1 7.6 6.3 5.3

EV/Sales (x) 4.0 3.4 2.8 2.4

EV/EBITDA (x) 24.4 19.6 16.3 13.7

Dividend yield (%) 0.9 1.0 1.2 1.5

Page 26: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

26 Edelweiss Securities Limited

Consumer Goods

Top 10 holdings

Perc. Holding Perc. Holding

Genesis Indian Inv Co Ltd 7.93 HFDC Asset Management Co Ltd 1.64

Wasatch Advisors Inc 1.33 Templeton Asset Mgmt 1.04

First State Investments Icvc 0.45 Dimensional Fund Advisors Lp 0.24

SBI Funds Management 0.21 Axis Asset Management Co Ltd 0.18

Blackrock Group Limited 0.17 UTI Asset Management Co Ltd 0.17

*as per last available data

Insider Trades Reporting Data Acquired / Seller B/S Qty Traded

No data available

*in last one year

Bulk Deals Data Acquired / Seller B/S Qty Traded Price

No Data Available

*in last one year

Additional Data

Directors Data

Shri S K Parekh Promoter/ Vice Chairman/ Non-Executive Director Shri Bansi S Mehta Non Executive Director/ Independent Director

Shri M B Parekh Promoter/ Managing Director/ Executive Director Shri Ranjan Kapur Non Executive Director/ Independent Director

Shri N K Parekh Promoter/ Joint Managing Director/ Executive Director Shri Yash Mahajan Non Executive Director/ Independent Director

Shri A B Parekh Promoter/ Whole Time Director/ Executive Director Shri Bharat Puri Non Executive Director/ Independent Director

Shri A N Parekh Promoter/ Whole Time Director/ Executive Director Shri D Bhattacharya Non Executive Director/ Independent Director

Shri R M Gandhi Non Executive Director/ Independent Director Shri Sanjeev Aga Non Executive Director/ Independent Director

Auditors - M/s Deloitte Haskins & Sells - Chartered Accountants

*as per last annual report

Page 27: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

27 Edelweiss Securities Limited

Company Absolute

reco

Relative

reco

Relative

risk

Company Absolute

reco

Relative

reco

Relative

Risk

Asian Paints BUY SP M Bajaj Corp BUY SP M

Colgate HOLD SU M Dabur BUY SO M

Emami BUY SP H GlaxoSmithKline Consumer

Healthcare

HOLD SP M

Godrej Consumer BUY SO H Hindustan Unilever HOLD SU L

ITC BUY SO L Marico BUY SP M

Nestle Ltd HOLD SP L United Spirits BUY SO H

RATING & INTERPRETATION

ABSOLUTE RATING

Ratings Expected absolute returns over 12 months

Buy More than 15%

Hold Between 15% and - 5%

Reduce Less than -5%

RELATIVE RETURNS RATING

Ratings Criteria

Sector Outperformer (SO) Stock return > 1.25 x Sector return

Sector Performer (SP) Stock return > 0.75 x Sector return

Stock return < 1.25 x Sector return

Sector Underperformer (SU) Stock return < 0.75 x Sector return

Sector return is market cap weighted average return for the coverage universe

within the sector

RELATIVE RISK RATING

Ratings Criteria

Low (L) Bottom 1/3rd percentile in the sector

Medium (M) Middle 1/3rd percentile in the sector

High (H) Top 1/3rd percentile in the sector

Risk ratings are based on Edelweiss risk model

SECTOR RATING

Ratings Criteria

Overweight (OW) Sector return > 1.25 x Nifty return

Equalweight (EW) Sector return > 0.75 x Nifty return

Sector return < 1.25 x Nifty return

Underweight (UW) Sector return < 0.75 x Nifty return

Page 28: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

28 Edelweiss Securities Limited

Consumer Goods

Edelweiss Securities Limited, Edelweiss House, off C.S.T. Road, Kalina, Mumbai – 400 098.

Board: (91-22) 4009 4400, Email: [email protected]

Vikas Khemani Head Institutional Equities [email protected] +91 22 2286 4206

Nischal Maheshwari Co-Head Institutional Equities & Head Research [email protected] +91 22 4063 5476

Nirav Sheth Head Sales [email protected] +91 22 4040 7499

Coverage group(s) of stocks by primary analyst(s): Consumer Goods

Asian Paints, Bajaj Corp, Colgate, Dabur, Godrej Consumer , Emami, Hindustan Unilever, ITC, Marico, Nestle Ltd, GlaxoSmithKline Consumer Healthcare,

United Spirits

Distribution of Ratings / Market Cap

Edelweiss Research Coverage Universe

Rating Distribution* 127 44 8 180

* 1 stocks under review

Market Cap (INR) 112 54 14

Date Company Title Price (INR) Recos

Recent Research

26-Nov-13 United

Spirits

High on W&M potential stake

Sale; Edelflash

2,622 Buy

22-Nov-13 Consumer

Goods

Margins Healthy, Volumes

divergent;

Result Review

18-Nov-13 ITC Forays into nicotine gums;

EdelFlash

314 Buy

> 50bn Between 10bn and 50 bn < 10bn

Buy Hold Reduce Total

Rating Interpretation

Buy appreciate more than 15% over a 12-month period

Hold appreciate up to 15% over a 12-month period

Reduce depreciate more than 5% over a 12-month period

Rating Expected to

Page 29: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

29 Edelweiss Securities Limited

Pidilite

DISCLAIMER

General Disclaimer:

This report has been prepared by Edelweiss Securities Limited (Edelweiss). Edelweiss, its holding company and associate

companies are a full service, integrated investment banking, portfolio management and brokerage group. Our research analysts

and sales persons provide important input into our investment banking activities. This report does not constitute an offer or

solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information

contained herein is from publicly available data or other sources believed to be reliable, but we do not represent that it is

accurate or complete and it should not be relied on as such. Edelweiss or any of its affiliates/ group companies shall not be in any

way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in

this report. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an

investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should

make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of

companies referred to in this report (including the merits and risks involved), and should consult his own advisors to determine

the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. We

and our affiliates, group companies, officers, directors, and employees may: (a) from time to time, have long or short positions in,

and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such

securities and earn brokerage or other compensation or act as advisor or lender/borrower to such company (ies) or have other

potential conflict of interest with respect to any recommendation and related information and opinions. This information is

strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or

redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any

purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or

located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be

contrary to law, regulation or which would subject Edelweiss and affiliates/ group companies to any registration or licensing

requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons

in whose possession this report comes, should inform themselves about and observe, any such restrictions. The information given

in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this

information. This information is subject to change without any prior notice. Edelweiss reserves the right to make modifications

and alterations to this statement as may be required from time to time. However, Edelweiss is under no obligation to update or

keep the information current. Nevertheless, Edelweiss is committed to providing independent and transparent recommendation

to its client and would be happy to provide any information in response to specific client queries. Neither Edelweiss nor any of its

affiliates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct,

indirect, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the

information. Past performance is not necessarily a guide to future performance. The disclosures of interest statements

incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the

views expressed in the report. Edelweiss Securities Limited generally prohibits its analysts, persons reporting to analysts and their

dependents from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. The

information provided in these reports remains, unless otherwise stated, the copyright of Edelweiss. All layout, design, original

artwork, concepts and other Intellectual Properties, remains the property and copyright Edelweiss and may not be used in any

form or for any purpose whatsoever by any party without the express written permission of the copyright holders.

Analyst Certification:

The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about

the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or

indirectly related to specific recommendations or views expressed in this report.

Analyst holding in the stock: No.

Edelweiss shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason

including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server

breakdown, maintenance shutdown, breakdown of communication services or inability of the Edelweiss to present the data. In no

event shall the Edelweiss be liable for any damages, including without limitation direct or indirect, special, incidental, or

consequential damages, losses or expenses arising in connection with the data presented by the Edelweiss through this

presentation.

Page 30: Pidilite - initiating coverage-Nov-13-EDELbsmedia.business-standard.com/_media/bs/data/market-reports/equity... · Edelweiss Research is also available on www ... and the Elastomer

30 Edelweiss Securities Limited

Consumer Goods

Access the entire repository of Edelweiss Research on www.edelresearch.com

Disclaimer for U.S. Persons

This research report is a product of Edelweiss Securities Limited, which is the employer of the research analyst(s) who has

prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States

(U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to

supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required

to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public

appearances and trading securities held by a research analyst account.

This report is intended for distribution by Edelweiss Securities Limited only to "Major Institutional Investors" as defined by Rule

15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and

Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as

specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied,

duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor.

In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC

in order to conduct certain business with Major Institutional Investors, Edelweiss Securities Limited has entered into an

agreement with a U.S. registered broker-dealer, Enclave Capital, LLC ("Enclave").

Transactions in securities discussed in this research report should be effected through Enclave Capital, LLC.

Disclaimer for U.K. Persons

The contents of this research report have not been approved by an authorised person within the meaning of the Financial

Services and Markets Act 2000 ("FSMA").

In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional

experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the

“Order”); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated

associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being

referred to as “relevant persons”).

This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment

activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant

persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This

research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other

person.

Disclaimer for Canadian Persons

This research report is a product of Edelweiss Securities Limited ("ESL"), which is the employer of the research analysts who have

prepared the research report. The research analysts preparing the research report are resident outside the Canada and are not

associated persons of any Canadian registered adviser and/or dealer and, therefore, the analysts are not subject to supervision by

a Canadian registered adviser and/or dealer, and are not required to satisfy the regulatory licensing requirements of the Ontario

Securities Commission, other Canadian provincial securities regulators, the Investment Industry Regulatory Organization of

Canada and are not required to otherwise comply with Canadian rules or regulations regarding, among other things, the research

analysts' business or relationship with a subject company or trading of securities by a research analyst.

This report is intended for distribution by ESL only to "Permitted Clients" (as defined in National Instrument 31-103 ("NI 31-103"))

who are resident in the Province of Ontario, Canada (an "Ontario Permitted Client"). If the recipient of this report is not an

Ontario Permitted Client, as specified above, then the recipient should not act upon this report and should return the report to

the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any Canadian person.

ESL is relying on an exemption from the adviser and/or dealer registration requirements under NI 31-103 available to certain

international advisers and/or dealers. Please be advised that (i) ESL is not registered in the Province of Ontario to trade in

securities nor is it registered in the Province of Ontario to provide advice with respect to securities; (ii) ESL's head office or

principal place of business is located in India; (iii) all or substantially all of ESL's assets may be situated outside of Canada; (iv)

there may be difficulty enforcing legal rights against ESL because of the above; and (v) the name and address of the ESL's agent for

service of process in the Province of Ontario is: Bamac Services Inc., 181 Bay Street, Suite 2100, Toronto, Ontario M5J 2T3 Canada.

Copyright 2009 Edelweiss Research (Edelweiss Securities Ltd). All rights reserved